KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) EBITDA (2016 - 2019)

Historic EBITDA for National Health Investors (NHI) over the last 11 years, with Q3 2019 value amounting to $62.4 million.

  • National Health Investors' EBITDA rose 561.12% to $62.4 million in Q3 2019 from the same period last year, while for Sep 2019 it was $234.8 million, marking a year-over-year increase of 301.47%. This contributed to the annual value of $294.4 million for FY2019, which is 686.52% up from last year.
  • Latest data reveals that National Health Investors reported EBITDA of $62.4 million as of Q3 2019, which was up 561.12% from $59.0 million recorded in Q2 2019.
  • In the past 5 years, National Health Investors' EBITDA ranged from a high of $62.4 million in Q3 2019 and a low of $33.3 million during Q2 2016
  • Over the past 5 years, National Health Investors' median EBITDA value was $55.6 million (recorded in 2018), while the average stood at $53.9 million.
  • As far as peak fluctuations go, National Health Investors' EBITDA surged by 12684.73% in 2015, and later tumbled by 3834.03% in 2016.
  • Quarter analysis of 5 years shows National Health Investors' EBITDA stood at $55.7 million in 2015, then increased by 11.73% to $62.2 million in 2016, then dropped by 9.04% to $56.6 million in 2017, then grew by 4.46% to $59.1 million in 2018, then increased by 5.61% to $62.4 million in 2019.
  • Its EBITDA stands at $62.4 million for Q3 2019, versus $59.0 million for Q2 2019 and $54.2 million for Q1 2019.